Ziege anti-Meerschweinchen IgG (F(ab')2 Region) Antikörper - Preadsorbed
-
- Target Alle IgG Produkte
- IgG
-
Bindungsspezifität
- F(ab')2 Region
-
Reaktivität
- Meerschweinchen
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Applikation
- ELISA, Immunohistochemistry (IHC), Western Blotting (WB)
- Spezifität
- IgG F(ab')2
- Produktmerkmale
- Concentration Definition: by UV absorbance at 280 nm
- Aufreinigung
- Preadsorption: Solid phase absorption
- Sterilität
- Sterile filtered
- Immunogen
-
Immunogen: Guinea Pig IgG F(ab')2 fragment
- Isotyp
- IgG
-
-
- Applikationshinweise
-
Immunohistochemistry Dilution: 1:1,000 - 1:5,000
Application Note: Anti-Guinea Pig IgG F(ab')2 antibody is suitable for ELISA, western blot, and immunohistochemistry, as well as other assays requiring lot-to-lot consistency.
ELISA Dilution: 1:20,000 - 1:100,000
Western Blot Dilution: 1:2,000 - 1:10,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 5.0 mg/mL
- Buffer
-
Buffer: 0.01 M Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Stabilizer: None
Preservative: 0.01 % (w/v) Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Haltbarkeit
- 12 months
-
- Target
- IgG
- Abstract
- IgG Produkte
- Substanzklasse
- Antibody
- Hintergrund
-
Synonyms: Goat Anti-Guinea Pig IgG F(ab')2 Antibody, Goat Anti Guinea Pig IgG F(ab')2 Antibody, Goat Anti Guinea Pig IgG Fab2 Fragment Antibody
Background: Anti-Guinea Pig IgG F(ab')2 Antibody generated in goat is a proteolytic fragment of immunoglobulin G (IgG) obtained by limited digestion with the enzyme pepsin under controlled conditions of temperature, time and pH . F(ab')2 Molecules lack the Fc portion of IgG and therefore receptors that bind Guinea Pig IgG F(c) will not bind Guinea Pig IgG F(ab')2 Molecules. Secondary Antibodies are available in a variety of formats and conjugate types. When choosing a secondary antibody product, consideration must be given to species and immunoglobulin specificity, conjugate type, fragment and chain specificity, level of cross-reactivity, and host-species source and fragment composition.
-